tiprankstipranks
Trending News
More News >
Trueblue Inc (TBI)
NYSE:TBI
US Market
Advertisement

Trueblue (TBI) AI Stock Analysis

Compare
95 Followers

Top Page

TBI

Trueblue

(NYSE:TBI)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 4o)
Rating:43Neutral
Price Target:
$5.50
▼(-0.90% Downside)
Trueblue's overall stock score is primarily impacted by its weak financial performance and bearish technical indicators. The negative valuation further contributes to the low score. While strategic initiatives from the earnings call offer some hope, they are not enough to offset current challenges.
Positive Factors
Strategic Acquisitions
The acquisition of HSP expands TrueBlue's market presence in high-growth sectors like health care, potentially doubling its addressable market and driving long-term growth.
Cost Reduction
Significant cost reductions enhance operational efficiency and profitability, providing a buffer against industry downturns and supporting long-term financial stability.
Digital Transformation
AI integration improves operational efficiency and client satisfaction, potentially leading to higher fill rates and competitive advantage in the staffing industry.
Negative Factors
Flat Revenue Growth
Flat revenue growth indicates challenges in expanding market share and demand, potentially limiting future profitability and growth opportunities.
Gross Margin Decline
Declining gross margins suggest cost pressures and inefficiencies, which could hinder profitability and require strategic adjustments to improve financial performance.
Net Loss
Reporting a net loss highlights financial instability and the need for improved cost management and revenue generation to ensure long-term viability.

Trueblue (TBI) vs. SPDR S&P 500 ETF (SPY)

Trueblue Business Overview & Revenue Model

Company DescriptionTrueBlue, Inc., together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The PeopleReady segment offers contingent staffing solutions for blue-collar, on-demand, and skilled labor in construction, manufacturing and logistics, warehousing and distribution, waste and recycling, energy, retail, hospitality, and general labor industries. The PeopleManagement segment provides contingent labor and outsourced industrial workforce solutions. This segment also offers on-site management and recruitment for the contingent industrial workforce of manufacturing, warehouse, and distribution facilities; and recruitment and management of contingent and dedicated commercial drivers to the transportation and distribution industries under the Staff Management, SIMOS Insourcing Solutions, and Centerline Drivers brands. The PeopleScout segment offers permanent employee recruitment process outsourcing services; and manages clients' contingent labor programs comprising vendor selection, performance management, compliance monitoring, and risk management. The company was formerly known as Labor Ready, Inc. and changed its name to TrueBlue, Inc. in December 2007. TrueBlue, Inc. was incorporated in 1985 and is headquartered in Tacoma, Washington.
How the Company Makes MoneyTrueblue generates revenue primarily through its staffing and recruitment services. The company earns money by charging clients a fee for each worker placed, which can be based on a percentage of the employee's wage or a flat fee arrangement. Key revenue streams include temporary staffing services, where they provide workers on a short-term basis, and permanent placement services, where they connect businesses with candidates for long-term employment. Additionally, Trueblue has established significant partnerships with various organizations and companies, which help to secure large contracts and consistent revenue. The company's ability to adapt its offerings to meet the specific needs of different industries also contributes to its earnings.

Trueblue Earnings Call Summary

Earnings Call Date:Aug 04, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Oct 27, 2025
Earnings Call Sentiment Neutral
The earnings call presented a mixed picture. While there were significant strategic advancements in market expansion, digital innovation, and cost efficiency, the company faced challenges with flat revenue growth, margin declines, and reporting a net loss. Positive momentum in skilled segments and strategic acquisitions provide optimism for future growth.
Q2-2025 Updates
Positive Updates
Expansion and Strategic Acquisitions
TrueBlue strategically expanded its total addressable market from $45 billion to $90 billion with the acquisition of health care staffing professionals (HSP), enhancing its presence in high-growth sectors like health care.
Cost Reduction and Efficiency Improvements
The company implemented $90 million in permanent SG&A savings from its 2022 base, driving margin expansion during the industry downturn.
Growth in Skilled and Energy Segments
TrueBlue's skilled businesses delivered double-digit growth for the quarter, and the commercial driver business achieved its fourth consecutive quarter of double-digit revenue growth.
Digital Transformation and Innovation
The company integrated AI into its platform strategies, enhancing job matching and predictive analytics, leading to improved fill rates and client satisfaction.
Negative Updates
Flat Total Revenue
Total revenue for the quarter was $396 million, flat compared to the prior year, with temporary labor and permanent hiring volumes remaining suppressed.
Gross Margin Decline
Gross margin fell by 280 basis points to 23.6%, driven by revenue mix changes and non-cash software depreciation costs.
Net Loss Reported
The company reported a net loss of $0.2 million for the quarter, including a non-cash intangible asset impairment charge.
PeopleSolutions Segment Decline
PeopleSolutions segment experienced a 20% organic revenue decline, despite a 40% inorganic growth contribution from HSP.
Company Guidance
During the TrueBlue Second Quarter 2025 Earnings Call, the company provided guidance that highlights a strategic framework aimed at fostering growth and enhancing shareholder value amid a challenging market environment. TrueBlue reported total revenue of $396 million for the quarter, with a flat performance compared to the previous year and a 4% growth contribution from the recent acquisition of Health Care Staffing Professionals (HSP). The company's gross margin declined by 280 basis points to 23.6%, attributed to changes in revenue mix and certain software depreciation. Despite these challenges, TrueBlue has implemented targeted cost reductions, achieving approximately $90 million in permanent SG&A savings from its 2022 base, which has helped drive improved efficiencies and profitability. Looking ahead to the third quarter, TrueBlue expects revenue growth between 5% and 11% year-over-year. The company is leveraging its digital transformation, expanding into high-growth markets, and optimizing its sales function to capture demand, supported by a robust innovation pipeline focused on integrating responsible AI into its platform strategies.

Trueblue Financial Statement Overview

Summary
Trueblue's financial performance is challenged by declining revenue, negative profit margins, and cash flow issues. The balance sheet shows manageable leverage but negative ROE, indicating poor shareholder returns. Overall, financial health requires strategic improvements.
Income Statement
45
Neutral
Trueblue's income statement shows a challenging financial position with declining revenue and profitability. The TTM data reveals a slight revenue growth of 0.4%, but the company is struggling with negative net profit and EBIT margins, indicating operational inefficiencies. The gross profit margin has decreased slightly from previous years, reflecting pressure on cost management. Overall, the income statement suggests a need for strategic improvements to enhance profitability.
Balance Sheet
55
Neutral
The balance sheet presents a moderate financial position with a manageable debt-to-equity ratio of 0.36 in the TTM period, indicating a relatively low level of leverage. However, the return on equity is negative, reflecting the company's inability to generate positive returns for shareholders. The equity ratio remains stable, suggesting a balanced asset structure. While the debt levels are under control, the negative ROE highlights the need for improved profitability.
Cash Flow
40
Negative
Cash flow analysis indicates significant challenges, with negative operating and free cash flows in the TTM period. The free cash flow growth rate is positive, but the operating cash flow to net income ratio is negative, highlighting cash flow management issues. The free cash flow to net income ratio is above 1, suggesting that despite losses, the company is generating some free cash flow relative to net income. Overall, cash flow management needs improvement to support financial stability.
BreakdownTTMDec 2024Dec 2023Dec 2019Dec 2018Dec 2017
Income Statement
Total Revenue1.53B1.57B1.91B2.37B2.50B2.51B
Gross Profit375.52M406.39M506.06M626.16M665.60M634.47M
EBITDA-12.76M-3.54M11.46M103.73M114.97M123.68M
Net Income-33.85M-125.75M-14.17M63.07M65.75M55.46M
Balance Sheet
Total Assets672.78M675.38M899.38M1.14B1.11B1.11B
Cash, Cash Equivalents and Short-Term Investments21.90M22.54M61.88M37.61M46.99M28.78M
Total Debt110.10M66.53M61.34M65.95M80.00M116.49M
Total Liabilities367.59M360.02M441.51M510.18M523.40M554.18M
Stockholders Equity305.19M315.36M457.87M625.97M591.44M554.85M
Cash Flow
Free Cash Flow-54.71M-41.21M3.48M66.42M108.64M77.89M
Operating Cash Flow-34.91M-17.06M34.75M94.54M125.69M99.85M
Investing Cash Flow-16.93M-2.45M-32.32M-25.08M-20.52M-30.90M
Financing Cash Flow48.55M-17.09M-37.58M-82.92M-75.02M-75.33M

Trueblue Technical Analysis

Technical Analysis Sentiment
Negative
Last Price5.55
Price Trends
50DMA
6.00
Negative
100DMA
6.28
Negative
200DMA
6.21
Negative
Market Momentum
MACD
-0.12
Positive
RSI
40.02
Neutral
STOCH
14.96
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TBI, the sentiment is Negative. The current price of 5.55 is below the 20-day moving average (MA) of 6.09, below the 50-day MA of 6.00, and below the 200-day MA of 6.21, indicating a bearish trend. The MACD of -0.12 indicates Positive momentum. The RSI at 40.02 is Neutral, neither overbought nor oversold. The STOCH value of 14.96 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TBI.

Trueblue Risk Analysis

Trueblue disclosed 36 risk factors in its most recent earnings report. Trueblue reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Trueblue Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
61
Neutral
$117.31M48.234.06%2.88%-9.76%-53.41%
53
Neutral
$83.55M102.311.01%5.16%
49
Neutral
$103.22M268.89-8.83%-8.31%-445.30%
49
Neutral
$40.89M-9.13%53.62%-24.36%-393.95%
48
Neutral
$438.66M11.43-0.49%2.41%0.97%-112.75%
43
Neutral
$165.95M-10.53%-13.01%68.18%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TBI
Trueblue
5.57
-1.70
-23.38%
DHX
DHI Group
2.13
0.29
15.76%
KELYA
Kelly Services
12.31
-7.63
-38.26%
MHH
Mastech Holdings
7.03
-2.80
-28.48%
BGSF
BGSF
3.73
-2.61
-41.17%
HQI
HireQuest
8.77
-5.07
-36.63%

Trueblue Corporate Events

Business Operations and StrategyFinancial Disclosures
TrueBlue Reports Improved Q2 2025 Financial Results
Positive
Aug 4, 2025

TrueBlue reported its second quarter 2025 financial results, showing a revenue of $396 million, which remained flat compared to the previous year. The company achieved a net loss of $0 million, a significant improvement from the $105 million net loss in the prior year, attributed to non-cash impairment and tax valuation charges. TrueBlue’s strategic focus on skilled trades, healthcare, and energy markets, along with investments in proprietary technologies, is expected to drive future growth and enhance operational efficiency. The company is optimistic about returning to growth in the third quarter, with a focus on retaining and expanding client relationships and delivering high-quality solutions.

The most recent analyst rating on (TBI) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Trueblue stock, see the TBI Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 03, 2025